17:24 EDT Outlook Therapeutics files to sell 516K shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OTLK:
- OTLK Earnings this Week: How Will it Perform?
- Outlook Therapeutics reports Q3 EPS (8c), consensus (5c)
- Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2023 and Reiterates Key Anticipated Near-Term Milestones
- Cantor biotech/biopharma analysts to hold analyst/industry conference call
- Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2023